Everpar Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Sell |
7,201
-132
| -2% | -$9.22K | 0.23% | 115 |
|
|
2025
Q1 | $539K | Sell |
7,333
-191
| -3% | -$14K | 0.29% | 85 |
|
|
2024
Q4 | $493K | Buy |
7,524
+69
| +0.9% | +$4.52K | 0.25% | 109 |
|
|
2024
Q3 | $581K | Sell |
7,455
-137
| -2% | -$10.7K | 0.3% | 89 |
|
|
2024
Q2 | $592K | Sell |
7,592
-26
| -0.3% | -$2.03K | 0.3% | 98 |
|
|
2024
Q1 | $516K | Sell |
7,618
-3,400
| -31% | -$230K | 0.31% | 101 |
|
|
2023
Q4 | $742K | Buy |
+11,018
| New | +$742K | 0.35% | 105 |
|